Insights

Compliance Readiness Valeant has faced accounting, pricing and governance scrutiny in recent years, signaling a need for strengthened regulatory compliance, anti corruption controls, internal audit capabilities, and pricing governance solutions.

Tech Modernization With SAP, SharePoint and the Microsoft stack in place, there is an opportunity to optimize ERP, analytics and collaboration platforms, including data integration and cloud migration to support scalable growth.

M&A Integration Valeant has a history of acquisitions, such as Bausch + Lomb and AcneFree, suggesting ongoing needs for post merger integration, product portfolio rationalization, and IT systems consolidation to realize synergies.

Product Launch Experience The company has launched Addyi after acquiring Sprout Pharmaceuticals, indicating experience with product launches and digital marketing; potential for targeted digital marketing analytics, physician engagement platforms and market access optimization for new products.

Mid market Opportunities As a mid sized pharma firm with a lean team, Valeant could benefit from scalable outsourcing across procurement, supply chain optimization, manufacturing efficiency and cost reduction programs, supported by vendor risk management and governance.

VALEANT Tech Stack

VALEANT uses 8 technology products and services including DNN, Salesforce, jQuery, and more. Explore VALEANT's tech stack below.

  • DNN
    Content Management System
  • Salesforce
    Customer Relationship Management
  • jQuery
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • Microsoft Word
    Office Suites
  • Microsoft Windows
    Operating Systems
  • Google Analytics
    Web Analytics
  • Microsoft ASP.NET
    Web Frameworks

Media & News

VALEANT's Email Address Formats

VALEANT uses at least 1 format(s):
VALEANT Email FormatsExamplePercentage
First.Last@valeant.comJohn.Doe@valeant.com
95%
FLast@valeant.comJDoe@valeant.com
4%
First.MiddleLast@valeant.comJohn.MichaelDoe@valeant.com
1%

Frequently Asked Questions

What is VALEANT's stock symbol?

Minus sign iconPlus sign icon
VALEANT is a publicly traded company; the company's stock symbol is VRX1.

What is VALEANT's official website and social media links?

Minus sign iconPlus sign icon
VALEANT's official website is valeant.com and has social profiles on LinkedIn.

What is VALEANT's NAICS code?

Minus sign iconPlus sign icon
VALEANT's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does VALEANT have currently?

Minus sign iconPlus sign icon
As of July 2026, VALEANT has approximately 112 employees across 5 continents, including North AmericaAsiaEurope. Key team members include Vp Business Development: M. O.Head Of Accounting And Finance: I. Y.Quality Compliance Director Emea: J. P.. Explore VALEANT's employee directory with LeadIQ.

What industry does VALEANT belong to?

Minus sign iconPlus sign icon
VALEANT operates in the Pharmaceutical Manufacturing industry.

What technology does VALEANT use?

Minus sign iconPlus sign icon
VALEANT's tech stack includes DNNSalesforcejQueryMicrosoftMicrosoft WordMicrosoft WindowsGoogle AnalyticsMicrosoft ASP.NET.

What is VALEANT's email format?

Minus sign iconPlus sign icon
VALEANT's email format typically follows the pattern of First.Last@valeant.com. Find more VALEANT email formats with LeadIQ.
VALEANT logo

VALEANT

Pharmaceutical Manufacturing51-200 Employees

Valeant Pharmaceuticals International, Inc. operates as a diversified, decentralized pharmaceutical company that aims to deliver consistent performance for its stakeholders. Its stated values provide direction and support in meeting challenges through teamwork and a competitive spirit. The company is part of the pharmaceutical manufacturing industry and is based in Canada, with a mid-sized workforce. This structure reflects a focus on stakeholder engagement and sustained performance.

In 2022, Valeant launched flibanserin (Addyi) in the U.S. market following its acquisition of Sprout Pharmaceuticals.

Section iconCompany Overview

Stock Symbol
VRX1
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
51-200

Section iconFunding & Financials

  • $250M$500M

    VALEANT's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    VALEANT's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.